ReviewEuropean clinical respiratory journal2025
Imaging of post-tuberculosis lung disease cases in children and adolescent survivors: a systematic review.
Review in European clinical respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Post-tuberculosis lung disease (PTLD) causes health problems among pulmonary TB (PTB) survivors. Post-TB patients may suffer from chronic respiratory symptoms, declining lung function, and persistent radiological abnormalities. However, studies regarding PTLD in children and adolescents are still scarce. Patterns of radiological abnormalities, including chest X-ray (CXR) imaging, high-resolution computed tomography (HRCT), and magnetic resonance imaging (MRI) in post-TB children, and adolescents are not fully understood. Aim: In this study, we aim to review and analyse radiological features in children and adolescent TB survivors of the literature on the differences in imaging findings in drug-resistant (DR) and drug-sensitive tuberculosis (DS TB) children and adolescent TB survivors. Method: We performed a systematic review to determine imaging patterns of DR and DS TB in children and adolescent survivors. Data collected include study design, number of subjects, age, TB category, treatment duration, time of evaluation, and imaging patterns. We searched MEDLINE/Pubmed, Google Scholar, Science Direct, Wiley Online Library, Cochrane Library, and Proquest and included four studies for data analysis. Study quality was assessed using a modified Newcastle-Ottawa score. Result: Studies included 151 children and adolescents aged 0-17 years. Three out of four studies were conducted on DS-TB patients and one study compared DS- and DR-TB. Radiological abnormalities observed by CXR at TB treatment completion include calcification in the presence or absence of fibrosis, bronchiectasis, and destroyed lung, or lymphoid interstitial pneumonitis. Micronodules are most often seen in HRCT in the acute early stages of TB and were not seen in standard chest radiography. Cavities persisted in almost 50% of patients after TB treatment and fibrotic changes increased after treatment. Conclusion: Imaging abnormalities after TB treatment are often seen in children and adolescents. Imaging evaluation should be performed in PTB survivors, especially in those with moderate or advanced lesions during active disease and those with severe clinical manifestations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.